P-Coumaric Acid

The strongest line, and the only one with human data on the isolate. Isolated p-coumaric acid has a structure that mimics L-tyrosine, letting it act as a competitive inhibitor of human tyrosinase — the rate-limiting enzyme of melanin synthesis — and it inhibited melanogenesis in human melanocytes and reconstructed skin, reportedly more potently against the human enzyme than arbutin or kojic acid ^{2Reference 2Boo YC · 2019Reviewp-Coumaric Acid as an Active Ingredient in Cosmetics: A Review Focusing on Its Antimelanogenic Effects — reviewView study →3Reference 3An SM et al. · 2010In vitrop-Coumaric acid not only inhibits human tyrosinase activity in vitro but also melanogenesis in cells exposed to UVB — in vitro / human melanocytesView study →}.

In a small controlled human study, a topical p-coumaric acid cream applied to the forearm markedly reduced UV-induced erythema and, with continued use, skin pigmentation ^{4Reference 4Seo YK et al. · 2011Clinical trialEffects of p-coumaric acid on erythema and pigmentation of human skin exposed to ultraviolet radiation — small human study (topical)View study →}.

The cinnamate chromophore also absorbs UV directly, adding a photoprotective mechanism on top of antioxidant quenching ^{2Reference 2Boo YC · 2019Reviewp-Coumaric Acid as an Active Ingredient in Cosmetics: A Review Focusing on Its Antimelanogenic Effects — reviewView study →}.

Gap: the human evidence is a single small topical study ^{4Reference 4Seo YK et al. · 2011Clinical trialEffects of p-coumaric acid on erythema and pigmentation of human skin exposed to ultraviolet radiation — small human study (topical)View study →}; there is no large trial, and the systemic (oral) route is undercut by conjugation, so this signal is essentially a topical one.

The foundational activity. As the isolated molecule, p-coumaric acid scavenges DPPH, peroxyl and other radicals and lowers lipid peroxidation; it was among the antioxidant phenolics identified in and contributing to the activity of the samambaia (Polypodium leucotomos) extract ^{11Reference 11Gombau L et al. · 2006In vitroPolypodium leucotomos extract: antioxidant activity and disposition — in vitro (samambaia; p-coumaric acid among the phenolics)View study →} and was one of the active radical-scavengers isolated from blue lotus flowers ^{14Reference 14Agnihotri VK et al. · 2008In vitroAntioxidant constituents of Nymphaea caerulea flowers — isolation / in vitro (blue lotus)View study →}.

Mono-phenol chemistry makes it a somewhat weaker direct scavenger than the catechol-bearing caffeic acid, but it is still a competent hydrogen/electron donor ^{1Reference 1Pei K et al. · 2016Reviewp-Coumaric acid and its conjugates: dietary sources, pharmacokinetic properties and biological activities — reviewView study →}.

Gap: most assays are cell-free or in-vitro on the free acid; in the body p-coumaric acid is rapidly conjugated (see Pharmacokinetics), so the circulating antioxidant is largely its glucuronide/sulfate conjugates, whose activity differs from the parent ^{1Reference 1Pei K et al. · 2016Reviewp-Coumaric acid and its conjugates: dietary sources, pharmacokinetic properties and biological activities — reviewView study →}.

Isolated p-coumaric acid inhibits platelet activity. In human platelets in vitro (500 µM–1 mM) and in rabbits fed 5 mg/kg for two weeks it reduced ADP-induced aggregation without affecting coagulation, an effect tied to lower thromboxane B2 production, reduced P-selectin expression and raised platelet cAMP, alongside increased plasma antioxidant capacity ^{5Reference 5Luceri C et al. · 2007In vitrop-Coumaric acid, a common dietary phenol, inhibits platelet activity in vitro and in vivo — in vitro human platelets + rabbit in vivoView study →}. It also appears among the phenolic acids credited with fennel’s vasoactive/antiplatelet fraction in cardiovascular reviews ^{16Reference 16Zahi A et al. · 2025ReviewCardiovascular effects, phytochemistry, drug interactions, and safety profile of Foeniculum vulgare (fennel): a comprehensive review — reviewView study →}, though that is whole-plant attribution.

Gap: the isolate data are in-vitro and a single rabbit study ^{5Reference 5Luceri C et al. · 2007In vitrop-Coumaric acid, a common dietary phenol, inhibits platelet activity in vitro and in vivo — in vitro human platelets + rabbit in vivoView study →}; no human cardiovascular endpoint, and the in-vitro concentrations are far above physiological free-acid plasma levels.

Isolated p-coumaric acid improves glycemic markers in rodents. In streptozotocin-diabetic rats it lowered blood glucose and gluconeogenic enzymes (glucose-6-phosphatase, fructose-1,6-bisphosphatase) while raising hexokinase and pancreatic GLUT2 expression, framed as protection of β-cell function ^{6Reference 6Amalan V et al. · 2016AnimalAntidiabetic and antihyperlipidemic activity of p-coumaric acid in diabetic rats, role of pancreatic GLUT 2: in vivo approach — rat modelView study →}; in high-fat-diet diabetic rats, 20 mg/kg for 12 weeks reduced hyperglycemia and attenuated oxidative kidney damage (diabetic nephropathy) ^{7Reference 7Mani A et al. · 2022Animalp-Coumaric acid attenuates high-fat diet-induced oxidative stress and nephropathy in diabetic rats — rat modelView study →}.

Gap: entirely rodent, with mechanisms that overlap heavily with the generic antioxidant action; no human metabolic data and no dose bridging to people ^{6Reference 6Amalan V et al. · 2016AnimalAntidiabetic and antihyperlipidemic activity of p-coumaric acid in diabetic rats, role of pancreatic GLUT 2: in vivo approach — rat modelView study →7Reference 7Mani A et al. · 2022Animalp-Coumaric acid attenuates high-fat diet-induced oxidative stress and nephropathy in diabetic rats — rat modelView study →}.

As the isolated molecule, p-coumaric acid kills bacteria through a dual mechanism — permeabilizing the outer and plasma membranes (loss of barrier function, ATP leakage, membrane hyperpolarization) and binding/intercalating bacterial genomic DNA to disrupt replication and transcription ^{10Reference 10Lou Z et al. · 2012In vitrop-Coumaric acid kills bacteria through dual damage mechanisms — in vitro mechanisticView study →}.

At the whole-plant level it is among the phenolic acids credited with the antibacterial activity of yerba maté extracts against S. aureus, Listeria and Salmonella ^{13Reference 13Prado Martin JG et al. · 2013In vitroAntimicrobial activity of yerba maté (Ilex paraguariensis) against food pathogens — in vitro (whole-extract)View study →}, and its lipophilic C16 ester (hexadecyl-coumaric-acid ester) is the anti-adhesion agent isolated from couchgrass rhizome against uropathogenic E. coli — though that ester is poorly water-extracted and is a different molecule from the free acid ^{12Reference 12Beydokhti SS et al. · 2017In vitroHexadecyl coumaric acid ester from the rhizomes of Agropyron repens with antiadhesive activity against uropathogenic E. coli — in vitro (couchgrass)View study →}.

Attribution should stay honest, though: in an antibiofilm screen of chelidonium and other Papaveraceae, activity tracked quercetin, and no correlation was found for the co-occurring p-coumaric acid ^{15Reference 15Zielińska S et al. · 2021In vitroScreening Papaveraceae as novel antibiofilm natural-based agents — in vitro (chelidonium; p-coumaric acid detected)View study →}.

Gap: the mechanistic work is in-vitro at high concentrations ^{10Reference 10Lou Z et al. · 2012In vitrop-Coumaric acid kills bacteria through dual damage mechanisms — in vitro mechanisticView study →}; the herb-level activity is extract- or ester-based, not clean isolate efficacy, and there is no in-vivo infection model for the free acid.